Visualization of membrane localization and functional state of CB2R pools by matched agonist and inverse agonist probe pairs

Marc Nazare,Malgorzata Wasinka-Kalwa,Anahid Omran,Leonard Mach,Jara Bouma,Lucia Scipioni,Xiaoting Li,Silke Radetzki,Yelena Mostinski,Maria Schippers,Thais Gazzi,Cas Horst van der,Benjamin Brennecke,Annaleah Hanske,Yuliya Kolomeets,Wolfgang Guba,Jens Peter von Kries,Johannes Broichhagen,Tian Hua,Dmitry Veprintsev,Laura Heitmann,Sergio Oddi,Mauro Maccarrone,Uwe Grether,David Sykes

DOI: https://doi.org/10.26434/chemrxiv-2024-q741f

2024-01-17

Abstract:The diversity of physiological roles of the endocannabinoid system has turned it into an attractive yet elusive therapeutic target. However, chemical probes with various functionalities could pave the way for a better understanding of the endocannabinoid system at the cellular level. Notably, inverse agonists of CB2R – a key receptor of the endocannabinoid system - lagged behind despite the evidence regarding the therapeutic potential of its antagonism. Herein, we report a matched fluorescent probe pair based on a common chemotype to address and visualize both the active and inactive states of CB2R, selectively. Alongside with extensive cross-validation by flow cytometry and confocal microscopy, we successfully visualize the intracellular localization of CB2R pools in live cells. The synthetic simplicity together with the high CB2R-selectivity and specificity of our probes, turn them into valuable tools in chemical biology and drug development that can benefit the clinical translatability of CB2R-based drug.

Chemistry

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a pair of fluorescent probes that can simultaneously visualize and distinguish the active and inactive states of CB2R (cannabinoid receptor 2). Specifically, the researchers designed a pair of fluorescent probes with highly similar chemical structures, which are respectively based on the verified CB2R agonists and inverse agonists. In this way, they hope to:

1. **Provide highly selective tools**: The developed probe pairs have high selectivity and specificity for CB2R and can be used for the study of CB2R expression, localization and functional state at the cellular level.
2. **Overcome the limitations of existing technologies**: Currently, the understanding of the distribution of the active and inactive states of CB2R is limited, especially the lack of probes that can effectively label the inactive state of CB2R. This poses a challenge to understanding the mechanism of action of CB2R under different physiological and pathological conditions.
3. **Promote drug development**: By providing tools that can monitor the real - time changes in CB2R activity in living cells, these probes are expected to accelerate drug development targeting CB2R, especially those drugs aimed at treating diseases such as inflammation, autoimmune diseases, metabolic disorders, chronic pain, multiple sclerosis and cancer.

To achieve the above goals, the researchers carried out detailed molecular design, synthesis and pharmacological characterization, and verified the effectiveness and specificity of the probes through techniques such as flow cytometry and confocal microscopy. Eventually, these probes not only showed good performance in cell experiments, but also revealed the complex distribution pattern of CB2R in living cells, especially providing new insights into the dynamic conversion between its active and inactive states.